Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LigoCyte Pharmaceuticals
Bozeman, Montana, USA
- Ownership
- Private
- Employees
- ~40
- Development stage
- Other
01
Overview
LigoCyte Pharmaceuticals was a biopharmaceutical company focused on the development of novel vaccines for gastrointestinal and respiratory diseases. The company utilized a proprietary Virus-Like Particle (VLP) platform technology to create vaccines that mimic the structure of viruses without being infectious. Its lead candidate was a first-in-class bivalent norovirus vaccine, which demonstrated clinical proof-of-concept in human challenge studies. LigoCyte was acquired by Takeda Pharmaceutical Company in 2012 to bolster Takeda's global vaccine business. The company's research and development efforts were primarily based in Bozeman, Montana.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineVirus-like particle
- Industry
- Biotech
02
Partnerships
GlaxoSmithKlineU.S. Army
Beyond the preview
Go deeper on LigoCyte Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LigoCyte Pharmaceuticals.